Deeks, Emma D.
240  Ergebnisse:
Personensuche X
?
2

Asciminib: First Approval:

Deeks, Emma D.
Drugs.  82 (2022)  2 - p. 219-226 , 2022
 
?
3

Disitamab Vedotin: First Approval:

Deeks, Emma D.
Drugs.  81 (2021)  16 - p. 1929-1935 , 2021
 
?
4

Difelikefalin: First Approval:

Deeks, Emma D.
Drugs.  81 (2021)  16 - p. 1937-1944 , 2021
 
?
5

Chiglitazar: First Approval:

Deeks, Emma D.
Drugs.  82 (2021)  1 - p. 87-92 , 2021
 
?
6

Abrocitinib: First Approval:

Deeks, Emma D. ; Duggan, Sean
Drugs.  81 (2021)  18 - p. 2149-2157 , 2021
 
?
7

Belzutifan: First Approval:

Deeks, Emma D.
Drugs.  81 (2021)  16 - p. 1921-1927 , 2021
 
?
8

Correction to: Odevixibat: First Approval:

Deeks, Emma D.
Drugs.  81 (2021)  15 - p. 1815-1815 , 2021
 
?
9

Anifrolumab: First Approval:

Deeks, Emma D.
Drugs.  81 (2021)  15 - p. 1795-1802 , 2021
 
?
10

Casirivimab/Imdevimab: First Approval:

Deeks, Emma D.
Drugs.  81 (2021)  17 - p. 2047-2055 , 2021
 
?
11

Odevixibat: First Approval:

Deeks, Emma D.
Drugs.  81 (2021)  15 - p. 1781-1786 , 2021
 
?
12

Atogepant: First Approval:

Deeks, Emma D.
Drugs.  82 (2021)  1 - p. 65-70 , 2021
 
?
13

Furmonertinib: First Approval:

Deeks, Emma D.
Drugs.  81 (2021)  15 - p. 1775-1780 , 2021
 
?
14

Solriamfetol in excessive daytime sleepiness: a profile of ..:

Deeks, Emma D. ; Heo, Young-A
Drugs & Therapy Perspectives.  36 (2020)  5 - p. 173-180 , 2020
 
1-15